Organogenesis Holdings (ORGO) Common Equity (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Common Equity of $244.6 million for Q1 2026, up 0.68% year-over-year from $242.9 million in Q1 2025, and down 18.52% quarter-over-quarter from $300.1 million in Q4 2025.
Organogenesis Holdings (ORGO) Common Equity (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Common Equity history runs 12 years deep, the most recent figure standing at $244.6 million for Q1 2026.
- In Q1 2026, Common Equity rose 0.68% year-over-year to $244.6 million; the TTM figure through Mar 2026 stood at $244.6 million (up 0.68% YoY), while the FY2025 annual figure was $300.1 million, up 14.16% from the prior year.
- Common Equity for Q1 2026 stood at $244.6 million, down from $300.1 million in the prior quarter.
- The five-year high for Common Equity was $300.1 million in Q4 2025, with the low at $233.2 million in Q2 2025.
- The 5-year median for Common Equity is $263.5 million (2024), against an average of $262.8 million.
- The sharpest annual moves came in 2022 and 2025: Common Equity jumped 57.84% in 2022, then dropped 12.63% in 2025.
- Organogenesis Holdings' Common Equity stood at $265.7 million in 2022, then gained by 4.89% to $278.7 million in 2023, then slipped by 5.66% to $262.9 million in 2024, then increased by 14.16% to $300.1 million in 2025, then declined by 18.52% to $244.6 million in 2026.
- Business Quant data shows ORGO's Common Equity at $244.6 million in Q1 2026, $300.1 million in Q4 2025, and $255.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 148.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 148.27 Mn |
| Mar 31, 2026 | 244.56 Mn |
| Dec 31, 2025 | 300.13 Mn |
| Sep 30, 2025 | 255.13 Mn |
| Jun 30, 2025 | 233.24 Mn |
| Mar 31, 2025 | 242.90 Mn |
| Dec 31, 2024 | 262.90 Mn |
| Sep 30, 2024 | 278.55 Mn |
| Jun 30, 2024 | 263.50 Mn |
| Mar 31, 2024 | 278.03 Mn |
| Dec 31, 2023 | 278.66 Mn |
| Sep 30, 2023 | 276.87 Mn |
| Jun 30, 2023 | 271.28 Mn |
| Mar 31, 2023 | 263.70 Mn |
| Dec 31, 2022 | 265.67 Mn |
| Sep 30, 2022 | 256.33 Mn |
| Jun 30, 2022 | 254.39 Mn |
| Mar 31, 2022 | 241.53 Mn |
| Dec 31, 2021 | 241.34 Mn |
| Sep 30, 2021 | 189.17 Mn |